Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yuefeng Li, Xiaofen Zhou, Qiongying Zhang, Endong Chen, Yihan Sun, Danrong Ye, Ouchen Wang, Xiaohua Zhang & Jianxin Lyu. (2019) Lipase member H is a downstream molecular target of hypoxia inducible factor-1α and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines. Cancer Management and Research 11, pages 931-941.
Read now
Read now
Articles from other publishers (18)
Jingjia Cao, Baojin Chen, Xiaolu Zhu, Yaru Sun, Xiao Li, Wei Zhang & Ximing Wang. (2023) BRAF V600E mutation in papillary thyroid microcarcinoma: is it a predictor for the prognosis of patients with intermediate to high recurrence risk?. Endocrine.
Crossref
Crossref
Adela Nechifor-Boilă, Ancuţa Zahan, Claudia Bănescu, Valeriu Moldovan, Doina Piciu, Septimiu Voidăzan & Angela Borda. (2023) Impact of BRAFV600E Mutation on Event-Free Survival in Patients with Papillary Thyroid Carcinoma: A Retrospective Study in a Romanian Population. Cancers 15:16, pages 4053.
Crossref
Crossref
Edmond Rukmana Wikanta, Yan Wisnu Prajoko, Benny Issakh, Hermawan Istiadi & Dik Puspasari. (2022) Relationship Between The BRAF V600E And Tumor Size, Lymph Node, And Distant Metastasis In Papillary Thyroid Carcinoma. Russian Open Medical Journal 11:2.
Crossref
Crossref
Xiaojing Wei, Xiaodong Wang, Jie Xiong, Chen Li, Yixuan Liao, Yongjun Zhu & Jingxin Mao. (2022) Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma. BioMed Research International 2022, pages 1-13.
Crossref
Crossref
Wojciech Gierlikowski, Katarzyna Broniarek, Łukasz Cheda, Zbigniew Rogulski & Marta Kotlarek-Łysakowska. (2021) MiR-181a-5p Regulates NIS Expression in Papillary Thyroid Carcinoma. International Journal of Molecular Sciences 22:11, pages 6067.
Crossref
Crossref
Karolina Skubisz, Joanna Januszkiewicz-Caulier, Patrycja Cybula, Elwira Bakuła-Zalewska, Krzysztof Goryca, Agnieszka Paziewska, Filip Ambrożkiewicz, Kosma Woliński, Michał Mikula, Jerzy Ostrowski & Marek Dedecjus. (2021) Higher EU-TIRADS-Score Correlated with BRAF V600E Positivity in the Early Stage of Papillary Thyroid Carcinoma. Journal of Clinical Medicine 10:11, pages 2304.
Crossref
Crossref
Sukaina Jaffar, Jayani Jayasekara, Ahmad M. Aniss, Venessa H. M. Tsang, Diana L. Learoyd, Roderick Clifton‐Bligh, Anthony J. Gill, Anothony R. Glover, Stan B. Sidhu, Bruce Robinson & Mark Sywak. (2021)
Predicting distant metastatic disease in differentiated thyroid cancer: a matched
case–control
study
. ANZ Journal of Surgery 91:4, pages 716-723.
Crossref
Crossref
Si-Yang Dong, Jie Chen, Er-Jie Xia, Ri-Xu Lin, Hai-Yan Du, Ou-Chen Wang, Xiao-Hua Zhang & Ru-Tian Hao. (2020)
Clinical Analysis of BRAF
V600E
Mutation and Its Correlation With Sonographic Image Characteristics in Papillary Thyroid Carcinoma in Chinese Coastal Areas
. The American Surgeon 86:5, pages 450-457.
Crossref
Crossref
Cuilin Li, Xiaowei Peng, Jing Lv, Hecun Zou, Jianqiu Liu, Ke Zhang & Zhi Li. (2020) SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer. Biomedicine & Pharmacotherapy 123, pages 109791.
Crossref
Crossref
Danuta Gąsior-Perczak, Artur Kowalik, Agnieszka Walczyk, Monika Siołek, Krzysztof Gruszczyński, Iwona Pałyga, Estera Mikina, Tomasz Trybek, Janusz Kopczyński, Ryszard Mężyk, Stanisław Góźdź & Aldona Kowalska. (2019) Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course. Cancers 11:11, pages 1744.
Crossref
Crossref
Aldona Kowalska, Agnieszka Walczyk, Artur Kowalik, Iwona Pałyga, Danuta Gąsior‐Perczak, Tomasz Trybek, Janusz Kopczyński, Maciej Kajor, Estera Mikina, Monika Szymonek, Klaudia Gadawska‐Juszczyk, Dorota Szyska‐Skrobot, Katarzyna Lizis‐Kolus, Stefan Hurej, Magdalena Chrapek, Małgorzata Chłopek & Stanisław Góźdź. (2017)
Response to therapy of papillary thyroid cancer of known
BRAF
status
. Clinical Endocrinology 87:6, pages 815-824.
Crossref
Crossref
Huy Gia Vuong, Ahmed MA Altibi, Uyen NP Duong, Hanh TT Ngo, Thong Quang Pham, Hung Minh Tran, Naoki Oishi, Kunio Mochizuki, Tadao Nakazawa, Lewis Hassell, Ryohei Katoh & Tetsuo Kondo. (2017)
Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of
TERT
promoter mutations and insignificant role of
BRAF
mutations—a meta-analysis
. Tumor Biology 39:10, pages 101042831771391.
Crossref
Crossref
Roy Lirov, Francis P. Worden & Mark S. Cohen. (2017) The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies. Drugs 77:7, pages 733-745.
Crossref
Crossref
Elisabetta Albi, Samuela Cataldi, Andrea Lazzarini, Michela Codini, Tommaso Beccari, Francesco Ambesi-Impiombato & Francesco Curcio. (2017) Radiation and Thyroid Cancer. International Journal of Molecular Sciences 18:5, pages 911.
Crossref
Crossref
Chunping Liu, Tianwen Chen & Zeming Liu. (2016) Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis. World Journal of Surgical Oncology 14:1.
Crossref
Crossref
Brendon Mitchell, Jagdish K. Dhingra & Meera Mahalingam. (2016) BRAF and Epithelial-Mesenchymal Transition: Lessons From Papillary Thyroid Carcinoma and Primary Cutaneous Melanoma. Advances in Anatomic Pathology 23:4, pages 244-271.
Crossref
Crossref
Rui Jiang, Chunming Zhao, Hao Xu, Miaoqing Zhao, Xiaogang Sun, Xinyu Wang & Wei Song. (2015)
Correlation between polymorphisms of
BRAF
gene and papillary thyroid carcinoma
. Clinical Endocrinology 84:3, pages 431-437.
Crossref
Crossref
Min Ji ChoKyoung Sik ParkMin Jeng ChoYoung Bum YooJung Hyun Yang. (2015) A comparative analysis of endoscopic thyroidectomy versus conventional thyroidectomy in clinically lymph node negative thyroid cancer. Annals of Surgical Treatment and Research 88:2, pages 69.
Crossref
Crossref